As of early 2026, only 13 state Medicaid programs cover GLP-1 medications for weight loss, down from 17 states at the start of the year California, New Hampshire, Pennsylvania, and South Carolina dropped coverage on January 1, 2026, citing budgetary constraints from the high cost of medications like Ozempic, Wegovy, and Zepbound
Enoglimab Engineered for seamless self-injection of Enoglimab, Wanhai Medical's pen injector ensures accurate, consistent dosing for GLP-1 receptor agonist therapy
Are There Any Side Effects Of A Vitamin B12 Shot
9 It's important to note that individual needs can vary based on factors like age, specific activity level, overall health status, and the degree of calorie restriction
By simultaneously activating the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors, it effectively promotes insulin secretion and reduces glucagon release, leading to better blood sugar regulation and weight loss support